CellRepMed's profile picture. Broad-scope #OA journal from @CellPressNews publishing cutting-edge science across the spectrum of #Translational and #ClinicalResearch | Editor: @DrSaraHam

Cell Reports Medicine

@CellRepMed

Broad-scope #OA journal from @CellPressNews publishing cutting-edge science across the spectrum of #Translational and #ClinicalResearch | Editor: @DrSaraHam

고정된 트윗

🎉 New Special Issue on cardiometabolism! 🎉 Recent advances in #atherosclerosis therapies, #inflammaging, and more, with a stunning cover from @Joseph_C_Wu lab. Don't miss expert insights on gender disparities by Dr. Susan Cheng and GLP-1R therapeutics from @DrGregSteinberg.


Online now: Intestinal Lachnospiraceae bacterium-derived propionate inhibits the progression of clear cell renal cell carcinoma dlvr.it/TNdFLm


Online now: A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity dlvr.it/TNcl1y


Online now: CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1 dlvr.it/TNcVFZ


Online now: ROR2-specific CAR T cells are effective against hematologic and solid tumors and well tolerated in mice dlvr.it/TNbX4t


Online now: Sintilimab plus chemotherapy for first-line treatment of advanced pulmonary lymphoepithelioma-like carcinoma: Phase 2 trial dlvr.it/TNZMdP


Online now: Comprehensive dissection of rectal cancer organoids in responses to chemoradiation dlvr.it/TNYfDv


Online now: 4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy dlvr.it/TNYKG4


Online now: In situ extended immune activation instantly after tumor resection by oncolytic virus controls postoperative tumor recurrence dlvr.it/TNXS2K


Online now: Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors—A phase 1/1b study dlvr.it/TNX6ZY


Online now: A sequential dual-site repetitive transcranial magnetic stimulation for major depressive disorder: A randomized clinical trial dlvr.it/TNWFJ5


Online now: Single-cell profiles delineate immune cell remodeling and enhanced tumor-fibroblast interaction of hepatoblastoma after chemotherapy dlvr.it/TNVqnn


Online now: Designer probiotic-based living drugs for uric acid homeostasis control in hyperuricemic mice and rats dlvr.it/TNV6dg


Online now: Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen density dlvr.it/TNTsKC


Online now: Multiplex base editing of BCL11A regulatory elements to treat sickle cell disease dlvr.it/TNTKw6


Online now: Chromosomal instability degrades developmental phenotypes essential for anti-GD2 immunotherapy outcomes in high-risk neuroblastoma dlvr.it/TNT4dC


We're excited to announce a panel discussion on the shifting regulatory and funding landscape in cell and gene therapies, happening @CellSymposia #CSStemCells2025 in Los Angeles, CA, next month! Register today to watch the discussion unfold: hubs.ly/Q03Ltcmn0

CellRepMed's tweet image. We're excited to announce a panel discussion on the shifting regulatory and funding landscape in cell and gene therapies, happening @CellSymposia #CSStemCells2025 in Los Angeles, CA, next month! 

Register today to watch the discussion unfold: hubs.ly/Q03Ltcmn0

Online now: Gut symbiont-derived ursodeoxycholic acid promotes fatty acid oxidation to protect against renal ischemia-reperfusion injury dlvr.it/TNQl8P


Online now: Phenotyping obesity through a two-dimensional tree structure reveals cardiometabolic heterogeneity dlvr.it/TNPxb9


Loading...

Something went wrong.


Something went wrong.